Examinando por Autor "Carrasco Arias, Dana Patricia"

Mostrando 1 - 1 de 1

Acceso abierto
Farmacovigilancia activa del producto farmacéutico Betriderm crema en usuarios de la botica Avi Pharma S.A.C., Lima 2023
(Universidad Privada Norbert Wiener, 2023-11-20) Carrasco Arias, Dana Patricia; Castillo Soto, Pedro Félix
Active pharmacovigilance is one of the methods used to assess information on the safety profile of medicines in relation to the characteristics of their consumers. The objective of this study was to establish the frequency of suspected adverse reactions in users of the pharmaceutical product Betriderm Cream, through an observational, prospective, analytical, and cross-sectional study, conducted in accordance with ethical and clinical guidelines. Sociodemographic characteristics revealed a mean age of 41.9 years (SD 15.2), mean weight of 64.4 kg (SD 12.4), and mean height of 159.0 cm (SD 9.4), with 63.1% being female. Medication use was mainly based on pharmaceutical recommendation (97.9%) and only 2.1% on self-medication, with 95.7% reporting three applications per day, predominantly for 1–3 days (71.9%). Participants reported healthy habits, such as fruit and vegetable consumption at least five days per week (55.6%), but also negative habits, including alcohol and cigarette use in 88.8%. Concomitant medications included naproxen (14.4%), ibuprofen (12.9%), omeprazole (8.6%), valsartan (7.2%), celecoxib (7.2%), paracetamol (7.2%), among others. The prevalence of suspected adverse reactions was 6.47%, corresponding to pruritus. It is concluded that the objectives were achieved, and the frequency observed corresponds to the category defined as very frequent manifestation.